[Antidepressant mechanism of Baihe Dihuang Decoction based on metabolomics and network pharmacology].

Q3 Pharmacology, Toxicology and Pharmaceutics Zhongguo Zhongyao Zazhi Pub Date : 2025-01-01 DOI:10.19540/j.cnki.cjcmm.20240712.710
Chao Hu, Hui Yang, Hong-Qing Zhao, Si-Qi Huang, Hong-Yu Liu, Shui-Han Zhang, Lin Tang
{"title":"[Antidepressant mechanism of Baihe Dihuang Decoction based on metabolomics and network pharmacology].","authors":"Chao Hu, Hui Yang, Hong-Qing Zhao, Si-Qi Huang, Hong-Yu Liu, Shui-Han Zhang, Lin Tang","doi":"10.19540/j.cnki.cjcmm.20240712.710","DOIUrl":null,"url":null,"abstract":"<p><p>The Baihe Dihuang Decoction(BDD) is a representative traditional Chinese medicine formula that has been used to treat depression. This study employed metabolomics and network pharmacology to investigate the mechanism of BDD in the treatment of depression. Fifty male Sprague-Dawley(SD) rats were randomly assigned to the normal control group, model group, fluoxetine group, and high-and low-dose BDD groups. A rat model of depression was established through chronic unpredictable mild stress(CUMS), and the behavioral changes were detected by forced swimming test and open field test. Metabolomics technology was used to analyze the metabolic profiles of serum and hippocampal tissue to screen differential metabolites and related metabolic pathways. Additionally, network pharmacology and molecular docking techniques were used to investigate the key targets and core active ingredients of BDD in improving metabolic abnormalities of depression. A &quot;component-target-metabolite-pathway&quot; regulatory network was constructed. BDD could significantly improve depressive-like behavior in CUMS rats and regulate 12 differential metabolites in serum and 27 differential metabolites in the hippocampus, involving tryptophan metabolism, phenylalanine, tyrosine, and tryptophan biosynthesis, alanine, aspartate, and glutamate metabolism, tyrosine metabolism, and purine metabolism. Verbascoside, isorbascoside, and regaloside B were the key active ingredients for improving metabolic abnormalities in depression. Epidermal growth factor receptor(EGFR), protooncogene tyrosine-protein kinase(SRC), glycogen synthase kinase 3β(GSK3β), and androgen receptor(AR) were the key core targets for improving metabolic abnormalities of depression. This study offered a preliminary insight into the mechanism of BDD in alleviating metabolic abnormalities of depression through network regulation, providing valuable guidance for its clinical use and subsequent research.</p>","PeriodicalId":52437,"journal":{"name":"Zhongguo Zhongyao Zazhi","volume":"50 1","pages":"10-20"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhongguo Zhongyao Zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19540/j.cnki.cjcmm.20240712.710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The Baihe Dihuang Decoction(BDD) is a representative traditional Chinese medicine formula that has been used to treat depression. This study employed metabolomics and network pharmacology to investigate the mechanism of BDD in the treatment of depression. Fifty male Sprague-Dawley(SD) rats were randomly assigned to the normal control group, model group, fluoxetine group, and high-and low-dose BDD groups. A rat model of depression was established through chronic unpredictable mild stress(CUMS), and the behavioral changes were detected by forced swimming test and open field test. Metabolomics technology was used to analyze the metabolic profiles of serum and hippocampal tissue to screen differential metabolites and related metabolic pathways. Additionally, network pharmacology and molecular docking techniques were used to investigate the key targets and core active ingredients of BDD in improving metabolic abnormalities of depression. A "component-target-metabolite-pathway" regulatory network was constructed. BDD could significantly improve depressive-like behavior in CUMS rats and regulate 12 differential metabolites in serum and 27 differential metabolites in the hippocampus, involving tryptophan metabolism, phenylalanine, tyrosine, and tryptophan biosynthesis, alanine, aspartate, and glutamate metabolism, tyrosine metabolism, and purine metabolism. Verbascoside, isorbascoside, and regaloside B were the key active ingredients for improving metabolic abnormalities in depression. Epidermal growth factor receptor(EGFR), protooncogene tyrosine-protein kinase(SRC), glycogen synthase kinase 3β(GSK3β), and androgen receptor(AR) were the key core targets for improving metabolic abnormalities of depression. This study offered a preliminary insight into the mechanism of BDD in alleviating metabolic abnormalities of depression through network regulation, providing valuable guidance for its clinical use and subsequent research.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[基于代谢组学和网络药理学的百合地黄汤抗抑郁机制研究]。
百合地黄汤(BDD)是一种具有代表性的中药配方,已被用于治疗抑郁症。本研究采用代谢组学和网络药理学方法探讨BDD治疗抑郁症的作用机制。将50只雄性SD大鼠随机分为正常对照组、模型组、氟西汀组和BDD高、低剂量组。采用慢性不可预测轻度应激法(CUMS)建立抑郁大鼠模型,并采用强迫游泳实验和野外实验检测其行为变化。利用代谢组学技术分析血清和海马组织的代谢谱,筛选差异代谢物和相关代谢途径。此外,利用网络药理学和分子对接技术,研究BDD改善抑郁症代谢异常的关键靶点和核心活性成分。一个“component-target-metabolite-pathway"构建监管网络。BDD可显著改善CUMS大鼠抑郁样行为,调节血清中12种差异代谢物和海马中27种差异代谢物,包括色氨酸代谢、苯丙氨酸、酪氨酸和色氨酸生物合成、丙氨酸、天冬氨酸和谷氨酸代谢、酪氨酸代谢和嘌呤代谢。毛蕊花糖苷、异山梨花糖苷和雷伽甲苷B是改善抑郁症代谢异常的关键活性成分。表皮生长因子受体(EGFR)、原癌基因酪氨酸蛋白激酶(SRC)、糖原合成酶激酶3β(GSK3β)和雄激素受体(AR)是改善抑郁症代谢异常的关键核心靶点。本研究初步揭示了BDD通过网络调控减轻抑郁症代谢异常的机制,为其临床应用及后续研究提供了有价值的指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Zhongguo Zhongyao Zazhi
Zhongguo Zhongyao Zazhi Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.50
自引率
0.00%
发文量
581
期刊介绍:
期刊最新文献
[Effects of different light qualities on field-grown Epimedium pubescens]. [Construction and evaluation of an animal model of Alzheimer's disease with spleen-kidney deficiency and stagnant phlegm syndrome based on formula test]. [Effects and mechanisms of Renshen Guben Oral Liquid combined with Jingfang Granules on ovarian aging in perimenopausal mice]. [Concentration and pharmacokinetics of dihydroartemisinin in Beagle dog plasma determined by UPLC-MS/MS]. [Evidence mapping analysis of clinical research on TCM for diabetic kidney disease in recent six years].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1